Form D · Biotechnology
Aureon Biosciences, Inc.
Yonkers, NY · CIK 0001331514
Offering snapshot reported Sep 29, 2011 · SEC filing
- Reported sold
- $16.8M Offering amount: $17.1M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 12, 2010 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$12,996,438 → $16,835,103
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2011 | Amendment | $16,835,103 | $3,838,665vs Jun 1, 2011 | 17 | SEC filing |
| Jun 1, 2011 | Amendment | $12,996,438 | $7,999,999vs Oct 25, 2010 | 17 | SEC filing |
| Oct 25, 2010 | Initial | $4,996,439 | No comparison | 17 | SEC filing |
| Aug 13, 2010 | Initial | $2,999,961 | No comparison | 17 | SEC filing |
| Mar 2, 2010 | Initial | $6,999,918 | No comparison | 17 | SEC filing |
| Jan 14, 2010 | Initial | $2,500,000 | No comparison | 16 | SEC filing |
| Aug 7, 2009 | Initial | $4,000,000 | No comparison | 16 | SEC filing |
| Oct 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-149520
Source: Form D, filed Sep 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vijay Aggarwal, Ph.D. | Director |
| Peter Barrett, Ph.D. | Director |
| William Burkoth | Director |
| Philippe Chambon, M.D., Ph.D. | Director |
| Carlos Cordon Cardo, M.D., Ph.D. | Director |
| Jose Costa, M.D. | Director |
| Kevin Johnson | Director |
| Robert Shovlin | Director, Executive |
| Robert Van Nostrand | Executive |
| Jose Velasco, M.D. | Director |
| Paul Veronese | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
28 Wells Ave
Yonkers, NY, 10701
Yonkers, NY, 10701